The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Costs of asthma are correlated with severity: a 1-yr prospective study
Open accessAbstract
Asthma prevalence is increasing and asthma-related costs are likely to increase, but few studies have analysed the relationship of asthma costs and severity. The impact of severity on costs was quantified in a cohort of 318 asthmatic patients followed up prospectively for 1 yr. Patients presenting with a broad range of severity of the disease (intermittent, mild persistent, moderate persistent, severe persistent) were recruited by chest physicians throughout France and treated for 1 yr according to customary clinical practice and following international guidelines. Severity, direct and indirect costs, and quality of life (QoL) were assessed. A multivariate analysis was conducted to relate factors contributing to the costs measured. Mean direct costs for goods and services excluding hospitalization, numbers of consultations, supplementary examinations, and the use and cost of bronchodilators and corticosteroids, indirect costs of days lost from work, and adverse QoL parameters all increased significantly with increasing severity. This also applied to mean age, body weight, asthma duration, depression of forced expiratory volume in one second, and inhaled corticosteroid posology in the 234 patients completing the study. There was a significant relationship (r=0.614, p<0.001) between direct costs (hospitalization and cures were excluded) and three domains of the QoL questionnaire (mobility, pain and energy). Overall costs of asthma (including individual direct costs, indirect costs, and intangible quality of life costs) are clearly related to severity. This is the first study in asthma to combine rigorous independent classification of grades of severity in statistically valid numbers of patients of grades receiving “real-world” treatment and followed-up prospectively for 1 yr. It allowed severity to be accurately related to direct, indirect and intangible costs of asthma. Quality of life explained a significant part of these costs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Eosinophilic Inflammation in Asthma
Bousquet, J., Chanez, P., Lacoste, J. Y., Barnéon, G., Ghavanian, N., Enander, I., Venge, P., Ahlstedt, S., Simony-Lafontaine, J., Godard, P., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199010113231505 · Cited by 2,499
Self-citationAn Economic Evaluation of Asthma in the United States
Weiss, K. B., Gergen, P. J., & Hodgson, T. A. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203263261304 · Cited by 995
Guidelines for the management of chronic obstructive pulmonary disease
Buist, A. S. (2002) · Respiratory Medicine · doi:10.1016/s0954-6111(02)80029-4 · Cited by 607
Crapo, R. O. (1994) · New England Journal of Medicine · doi:10.1056/nejm199407073310107 · Cited by 576
A National Estimate of the Economic Costs of Asthma
SMITH, D. H., MALONE, D. C., LAWSON, K. A., OKAMOTO, L. J., BATTISTA, C., & SAUNDERS, W. B. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.3.9611072 · Cited by 562
Barnes, P., Jonsson, B., & Klim, J. (1996) · European Respiratory Journal · doi:10.1183/09031936.96.09040636 · Cited by 434
Bentley, A. M., Menz, G., Storz, C., Robinson, D. S., Bradley, B., Jeffery, P. K., Durham, S. R., & Kay, A. B. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/146.2.500 · Cited by 407
Costs of asthma according to the degree of severity
Serra-Batlles, J., Plaza, V, Morejon, E., Comella, A., & Brugues, J. (1998) · European Respiratory Journal · doi:10.1183/09031936.98.12061322 · Cited by 387
Trends in the cost of illness for asthma in the United States, 1985-1994
Weiss, K. B., Sullivan, S. D., & Lyttle, C. S. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2000.109426 · Cited by 366
Inhaled corticosteroid use and bone-mineral density in patients with asthma
Wong, C. A., Walsh, L. J., Smith, C. J., Wisniewski, A. F., Lewis, S. A., Hubbard, R., Cawte, S., Green, D. J., Pringle, M., & Tattersfield, A. E. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02138-3 · Cited by 362
Cited by
Uncontrolled asthma: A review of the prevalence, disease burden and options for treatment
Peters, S. P., Ferguson, G., Deniz, Y., & Reisner, C. (2006) · Respiratory Medicine · doi:10.1016/j.rmed.2006.03.031 · Cited by 320
Guilbert, T. W., Bacharier, L. B., & Fitzpatrick, A. M. (2014) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2014.06.022 · Cited by 216
The prevalence of severe asthma and low asthma control among Danish adults
von Bülow, A., Kriegbaum, M., Backer, V., & Porsbjerg, C. (2014) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2014.05.005 · Cited by 154
van de Hei, S. J., Poot, C. C., van den Berg, L. N., Meijer, E., van Boven, J. F. M., Flokstra-de Blok, B. M. J., Postma, M. J., Chavannes, N. H., & Kocks, J. W. H. (2022) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2022-001400 · Cited by 22
de Mesa, E. G., Hidalgo, I., Christidis, P., Ciscar, J. C., Vegas, E., & Ibarreta, D. (2007) · Molecular Diagnosis & Therapy · doi:10.1007/bf03256252 · Cited by 9
Metadata
- Authors
- Godard, P., Chanez, P., Siraudin, L., Nicoloyannis, N., & Duru, G.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2001-01-01
- Volume
- 19
- Issue
- 1
- Pages
- 61-67
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2163779250
- Cited by
- 331
- References
- 25
- FWCI
- 3.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Costs of asthma are correlated with severity: a 1-yr prospective study. https://app.cochat.ai/papers/10.1183/09031936.02.00232001
- The paper
- Godard, P., Chanez, P., Siraudin, L., Nicoloyannis, N., & Duru, G. (2002). Costs of asthma are correlated with severity: a 1-yr prospective study. European Respiratory Journal. https://doi.org/10.1183/09031936.02.00232001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
